Noninvasive technology for the high-throughput characterization of cancer cells

byTokyo University of ScienceSchematic of a cell rotation movement in a rotating AC electric field for (a) conventional ROT and (b) newly developed cROT. In conventional ROT in (a), when AC volt

Updated on: January 02,2024

Noninvasive technology for the high-throughput characterization of cancer cells

byTokyo University of ScienceSchematic of a cell rotation movement in a rotating AC electric field for (a) conventional ROT and (b) newly developed cROT. In conventional ROT in (a), when AC volt

Updated on:January 02,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on: February 03,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on:February 03,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on: January 04,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on:January 04,2024

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on: April 12,2024

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on:April 12,2024

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec

Updated on: February 18,2024

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec

Updated on:February 18,2024

Rhombic lip implicated in origins of high-risk medulloblastoma

bySt. Jude Children's Research HospitalTranscriptional atlas of the human fetal cerebellum. (a) Schematic summary of the molecular datasets used to interconnect mouse and human cerebellar pr

Updated on: December 28,2023

Rhombic lip implicated in origins of high-risk medulloblastoma

bySt. Jude Children's Research HospitalTranscriptional atlas of the human fetal cerebellum. (a) Schematic summary of the molecular datasets used to interconnect mouse and human cerebellar pr

Updated on:December 28,2023

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on: February 20,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on:February 20,2024

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer

by Impact Journals LLCVolcano plot of significant differentially expressed genes with the left volcano being the discovery cohort and validation cohort on the right. Credit:Oncotarget(2022

Updated on: January 02,2024

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer

by Impact Journals LLCVolcano plot of significant differentially expressed genes with the left volcano being the discovery cohort and validation cohort on the right. Credit:Oncotarget(2022

Updated on:January 02,2024

Improving next-generation cancer treatments with cryoimmunotherapy

by Olivia Dimmer,Northwestern UniversityCredit:ACS Nano(2024). DOI: 10.1021/acsnano.4c05809Northwestern Medicine scientists have developed a more effective method of delivering a cut

Updated on: October 24,2024

Improving next-generation cancer treatments with cryoimmunotherapy

by Olivia Dimmer,Northwestern UniversityCredit:ACS Nano(2024). DOI: 10.1021/acsnano.4c05809Northwestern Medicine scientists have developed a more effective method of delivering a cut

Updated on:October 24,2024

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di

Updated on: January 26,2024

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di

Updated on:January 26,2024

Immune cell helps predict skin cancer patients' chances of responding to treatment

byKing's College Londona, Schematic of nonenzymatic extraction of lymphocytes from primary human tissue and subsequent expansion protocol. b, Summary flow cytometry data of Vδ1+cell en

Updated on: January 26,2024

Immune cell helps predict skin cancer patients' chances of responding to treatment

byKing's College Londona, Schematic of nonenzymatic extraction of lymphocytes from primary human tissue and subsequent expansion protocol. b, Summary flow cytometry data of Vδ1+cell en

Updated on:January 26,2024

Fighting liver cancer takes big financial toll: Study

by Cara MurezOut-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis withhepatoc

Updated on: January 16,2024

Fighting liver cancer takes big financial toll: Study

by Cara MurezOut-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis withhepatoc

Updated on:January 16,2024